TY - JOUR
T1 - Analysis of growth rate, haematologic, and biochemical parameters of Oncopigs
AU - Elkhadragy, Lobna
AU - Castillo, Caitlyn C.
AU - Li, Rena
AU - Bolt, Courtni R.
AU - Rund, Laurie
AU - Thomas, Faith
AU - Lane, Rachel
AU - Gaba, Ron C.
AU - Schook, Lawrence B.
AU - Schachtschneider, Kyle M.
N1 - This work was supported by the Department of Defense [CA150590], the National Institutes of Health, National Cancer Institute [1R01CA283548], the Department of Animal Sciences, University of Illinois at Urbana-Champaign, and the Department of Radiology, University of Illinois at Chicago. The authors greatly acknowledge all the lab members and veterinary staff who helped with Oncopig data and sample collection. We would also like to acknowledge services provided by the Statistics Core, Center for Clinical and Translational Science, at the University of Illinois at Chicago.
L.E. reports grants from United States National Institutes of Health and the Society of Interventional Radiology. C.R.B. reports working for Sus Clinicals. R.C.G. reports grants from United States National Institutes of Health, Guerbet USA LLC, Janssen Research & Development LLC, NeoTherma Oncology, TriSalus Life Sciences, and Sus Clinicals, Inc.; consulting fees from Boston Consulting Group; pending patent for Modeling Oncology on Demand, United States Provisional Patent Application No. 62/813,307; participation on Sus Clinicals, Inc. Scientific Advisory Board; participation on Fluidx Medical Technology Advisory board; participation on Kaveri University Advisory board; and stock or stock options in Sus Clinicals, Inc. L.B.S. and K.M.S. report grants from United States National Institutes of Health, United States Department of Agriculture, Society of Interventional Radiology, Guerbet USA LLC, Janssen Research & Development LLC, TriSalus Life Sciences, and Earli Inc.; work for Sus Clinicals; pending patents for Modeling Oncology on Demand, United States Provisional Patent Application No. 62/813,307, and Patch for Targeted Delivery of an Oncogenic Cargo to a Tissue, United States Patent Application No. 63/306,449. The remaining authors have no conflicts of interest to declare.
PY - 2025
Y1 - 2025
N2 - Pigs are widely used as large animal models in biomedical research due to their physiological and anatomical similarity to humans. The Oncopig, a genetically engineered pig model harbouring Cre recombinase-inducible KRASG12D and TP53R167H transgenes, serves as a valuable model for cancer research. This study describes the generation of Oncopig breeding herds and provides a characterization of their growth rate, body size, and physiological parameters, including haematologic, biochemical, and coagulation profiles. Body weight and size were measured in male and female Oncopigs, and blood samples were collected at multiple time points from birth to one year of age. A total of 13 haematologic, 18 biochemical, and 3 coagulation parameters were analysed. While male and female Oncopigs had a comparable growth rate within the first 6 months of age, male Oncopigs exhibited a significantly higher growth rate between 6 and 12 months of age and a higher body weight at 12 months. The mean body weight at 6 months of age was 52.3 kg for male Oncopigs and 48.0 kg for female Oncopigs, while at 11 months of age it was 96.4 kg for male Oncopigs and 71.7 kg for female Oncopigs. Haematologic, biochemical, and coagulation parameters were analysed for Oncopigs under 6 months of age, over 6 months, and collectively for Oncopigs within a year of age. By providing comprehensive data on growth, haematologic, and serum biochemical parameters, this study provides a critical resource for researchers utilizing Oncopigs as large animal models for cancer research and other translational studies.
AB - Pigs are widely used as large animal models in biomedical research due to their physiological and anatomical similarity to humans. The Oncopig, a genetically engineered pig model harbouring Cre recombinase-inducible KRASG12D and TP53R167H transgenes, serves as a valuable model for cancer research. This study describes the generation of Oncopig breeding herds and provides a characterization of their growth rate, body size, and physiological parameters, including haematologic, biochemical, and coagulation profiles. Body weight and size were measured in male and female Oncopigs, and blood samples were collected at multiple time points from birth to one year of age. A total of 13 haematologic, 18 biochemical, and 3 coagulation parameters were analysed. While male and female Oncopigs had a comparable growth rate within the first 6 months of age, male Oncopigs exhibited a significantly higher growth rate between 6 and 12 months of age and a higher body weight at 12 months. The mean body weight at 6 months of age was 52.3 kg for male Oncopigs and 48.0 kg for female Oncopigs, while at 11 months of age it was 96.4 kg for male Oncopigs and 71.7 kg for female Oncopigs. Haematologic, biochemical, and coagulation parameters were analysed for Oncopigs under 6 months of age, over 6 months, and collectively for Oncopigs within a year of age. By providing comprehensive data on growth, haematologic, and serum biochemical parameters, this study provides a critical resource for researchers utilizing Oncopigs as large animal models for cancer research and other translational studies.
KW - Oncopig
KW - cancer model
KW - growth chart
KW - haematologic and biochemical parameters
KW - large animal model
KW - transgenic pig
UR - https://www.scopus.com/pages/publications/105007289436
UR - https://www.scopus.com/pages/publications/105007289436#tab=citedBy
U2 - 10.1080/23144599.2025.2502711
DO - 10.1080/23144599.2025.2502711
M3 - Article
C2 - 40463985
AN - SCOPUS:105007289436
SN - 2314-4580
VL - 13
SP - 1
EP - 9
JO - International Journal of Veterinary Science and Medicine
JF - International Journal of Veterinary Science and Medicine
IS - 1
ER -